Why is Bliss GVS Pharma falling/rising?

As of 11-Nov, Bliss GVS Pharma Ltd is experiencing a price increase, currently at Rs 157.55, reflecting a rise of Rs 9.6 or 6.49%. The stock has shown strong performance today, outperforming its sector by 6.62%, and has gained consecutively over the last two days, resulting in a total return of 22.99% during this period. Additionally, the stock has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Despite a year-to-date decline of 4.31%, the stock has generated a robust return of 30.21% over the past year, significantly outperforming the broader market's return of 4.43%. The company also maintains a low debt-to-equity ratio and a fair valuation, contributing positively to investor sentiment.
In the broader market context, Bliss GVS Pharma's recent performance stands out, particularly in the short term, where it has outperformed the benchmark Sensex, which has only increased by 0.49% over the past week. However, there are concerns regarding the company's long-term growth potential, as evidenced by modest growth rates in net sales and operating profit over the past five years. Additionally, a decrease in institutional investor participation could signal caution among more sophisticated investors, potentially impacting future stock performance. Despite these challenges, the recent surge in trading volume and positive returns suggest that investor interest remains strong in the short term.